Current state of knowledge on primary Sjögren's syndrome, an autoimmune exocrinopathy

D Parisis, C Chivasso, J Perret, MS Soyfoo… - Journal of clinical …, 2020 - mdpi.com
Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune rheumatic disease
characterized by lymphoplasmacytic infiltration of the salivary and lacrimal glands, whereby …

Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms

A Papoudou-Bai, E Hatzimichael, A Barbouti… - Clinical and …, 2017 - Springer
Abstract The activator protein-1 (AP-1) is a dimeric transcription factor composed of proteins
belonging to the Jun (c-Jun, JunB and JunD), Fos (c-Fos, FosB, Fra1 and Fra2) and …

Bcl-xL is an oncogenic driver in colorectal cancer

AL Scherr, G Gdynia, M Salou, P Radhakrishnan… - Cell death & …, 2016 - nature.com
Colorectal cancer (CRC) is the second most common malignant neoplasia in women and
men worldwide. The B-cell lymphoma 2 (Bcl-2) protein family is mainly known for its pivotal …

MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B‐cell lymphoma (DLBCL), especially in germinal centre‐like B cell …

SO Yoon, YK Jeon, JH Paik, WY Kim, YA Kim… - …, 2008 - Wiley Online Library
Aims: Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous disease with various
genetic alterations. The aim was to investigate MYC, Bcl‐2 and Bcl‐6 translocations and …

Long non-coding RNAs modulate Sjögren's syndrome associated gene expression and are involved in the pathogenesis of the disease

M Dolcino, E Tinazzi, C Vitali, N Del Papa… - Journal of clinical …, 2019 - mdpi.com
Primary Sjögren's syndrome (pSjS) is a chronic systemic autoimmune disorder, primarily
affecting exocrine glands; its pathogenesis is still unclear. Long non-coding RNAs …

miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies

S Al-Harbi, GS Choudhary, JS Ebron, BT Hill… - Molecular cancer, 2015 - Springer
Background BCL-xL is an anti-apoptotic BCL-2 family protein that inhibits apoptosis and is
overexpressed in many cancers. We have reported that acquired resistance to the BCL-2 …

Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue

D Kalogeropoulos, A Papoudou-Bai… - Clinical and …, 2018 - Springer
Ocular adnexal lymphomas are a group of heterogeneous neoplasms representing
approximately 1–2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. The …

Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma

S Hasselblom, B Ridell, M Sigurdardottir… - Leukemia & …, 2008 - Taylor & Francis
The prognostic role of overexpression of Ki-67 protein in diffuse large B-cell lymphoma
(DLBCL) is still unclear. Furthermore, immunohistochemical studies have suggested a …

Primary lymphomas of bone

P Kitsoulis, M Vlychou, A Papoudou-Bai… - Anticancer …, 2006 - ar.iiarjournals.org
Primary lymphomas of bone are uncommon malignancies. The vast majority of them are non-
Hodgkin lymphoma (NHL), whereas primary Hodgkin lymphoma (HL) of bone is extremely …

Profiling of diffuse large B‐cell lymphoma by immunohistochemistry: identification of prognostic subgroups

LD Sjö, CB Poulsen, M Hansen… - European journal of …, 2007 - Wiley Online Library
Diffuse large B‐cell lymphoma (DLBCL) is a frequent lymphoma subtype with a
heterogeneous behavior and a variable response to conventional chemotherapy. This …